Expression of soluble toll-like receptors in pleural effusions

Chinese Medical Journal

Volumn 123, Issue 16, 2010, Pages 2225-2230

  Yang, Hai bo ^a   Xie, Kai qing ^b   Deng, Jing min ^a   Qin, Shou ming ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Diagnosis; Pleural effusion; Toll like receptor

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; LACTATE DEHYDROGENASE; PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; BLOOD ANALYSIS; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURA FLUID; SENSITIVITY AND SPECIFICITY; TUBERCULOUS PLEURISY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION; PROSPECTIVE STUDIES; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 77956104103     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.16.013     Document Type: Article

References (29)

1. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997; 91: 295-298.
2. Takeda K, Kaisho T, Akira S. Toll-like receptors. Ann Rev Immunol 2003; 21: 335-376.
3. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135-145.
4. Underhill DM, Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002; 14: 103-110.
5. Schröer NWJ, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005; 5: 156-164.
6. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1-14.
7. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999; 285: 732-736.
8. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163: 3920-3927.
9. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11: 443-451.
10. Bulut Y, Faure E, Thomas L, Equils O, Arditi M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 2001; 167: 987-994.
11. Jones BW, Means TK, Heldwein KA, Keen MA, Hill PJ, Belisle JT, et al. Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol 2001; 69: 1036-1044.
12. Means TK, Jones BW, Schromm AB, Shurtleff BA, Smith JA, Keane J, et al. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol 2001; 166: 4074-4082.
13. Sahn SA. State of the art. The pleura. Am Rev Respir Dis 1988; 138: 184-234.
14. Light RW. Clinical practice. Pleural effusion. N Engl J Med 2002; 346: 1971-1977.
15. Antony VB. Immunological mechanisms in pleural disease. Eur Respir J 2003; 21: 539-544.
16. Mutsaers SE. Mesothelial cells: their structure, function and role in serosal repair. Respirology 2002; 7: 171-191.
17. Dalbeth N, Lee YC. Lymphocytes in pleural disease. Curr Opin Pulm Med 2005; 11: 334-339.
18. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997; 10: 1150-1156.
19. Light RW, Macgregor MI, Luchsinger PC, Ball WC, Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77: 507-513.
20. Huang LY, Shi HZ, Liang QL, Wu YB, Qin XJ, Chen YQ. Expression of soluble triggering receptor expression on myeloid cells-1 in pleural effusion. Chin Med J 2008; 121: 1656-1661.
21. Hussain T, Nasreen N, Lai Y, Bellew BF, Antony VB, Mohammed KA. Innate immune responses in murine pleural mesothelial cells: Toll-like receptor-2 dependent induction of beta-defensin-2 by staphylococcal peptidoglycan. Am J Physiol Lung Cell Mol Physiol 2008; 295: L461-L470.
22. Prabha C, Rajashree P, Sulochana DD. TLR2 and TLR4 expression on the immune cells of tuberculous pleural fluid. Immunol Lett 2008; 117: 26-34.
23. Koller B, Kappler M, Latzin P, Gaggar A, Schreiner M, Takyar S, et al. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J Immunol 2008; 181: 2753-2763.
24. Mita Y, Dobashi K, Shimizu Y, Nakazawa T, Mori M. Toll-like receptor 2 and 4 surface expressions on human monocytes are modulated by interferon-gamma and macrophage colony-stimulating factor. Immunol Lett 2001; 78: 97-101.
25. Armstrong L, Medford AR, Uppington KM, Robertson J, Witherden IR, Tetley TD, et al. Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 2004; 31: 241-245.
26. Droemann D, Goldmann T, Branscheid D, Clark R, Dalhoff K, Zabel P, et al. Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung. Histochem Cell Biol 2003; 119: 103-108.
27. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007; 7: 179-190.
28. Burgess LJ, Maritz FJ, Taljaard JJ. Comparative analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest 1995; 107: 1604-1609.
29. Romero-Candeira S, Hernández L, Romero-Brufao S, Orts D, Fernández C, Martín C. Is it meaningful to use biochemical parameters to discriminate between transudative and exudative pleural effusions? Chest 2002; 122: 1524-1529.